Weekly Update March 3, 2021 featuring data analyst Juan Chamie and his insightful charts and graphs focused on ivermectin in South America.

Dr. Tess Lawrie, Director of the Evidence-based Medicine Consultancy in Bath, England, and a regular consultant to the WHO, on whether more Randomized Controlled Trials are needed for Ivermectin in COVID-19

Can Ivermectin Be Used to Treat COVID-19? Pulmonary and critical care specialist Dr. Pierre Kory appeared on The Doctors television show, which aired on February 8, 2021, to discuss whether ivermectin, which has been used for 40 years to treat head lice and many parasitic diseases, can be used to treat COVID-19.

Merck’s assessments of ivermectin’s efficacy in COVID-19 are in striking contrast with the findings reported by multiple expert group’s systematic reviews from across the globe.

The Efficacy of Ivermectin Against COVID‑19 is a lecture Dr Pierre Kory gave hosted by YPO Gold’s Southern California Chapter for hundreds of CEOs within the network internationally.

On January 6, 2021, Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data on ivermectin before the National Institutes of Health (NIH) Treatment Guidelines Panel.

Martin D. Hellwig a, Anabela Maia b https://doi.org/10.1016/j.ijantimicag.2020.106248 Abstract As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that lower incidence [...]

Khan MS, Khan MS, Debnath Cr et al. PMID: 33293006 PMCID: PMC7837160 DOI: 10.1016/j.arbres.2020.08.007 Abstract No abstract available Keywords: ivermectin Source: https://pubmed.ncbi.nlm.nih.gov/34629660/ Archive: https://archive.is/wip/67u8W

Fact Checking the Fact Checkers – The Case of Ivermectin for Publicly-Subsidized Research: On December 11, TrialSite News reported on a US Senate hearing at which, among other things, there was testimony urgently calling for more research and an EUA for ivermectin as both a prophylactic against and an early treatment for COVID-19.

At a press conference on Dec. 4, 2020, at United Memorial Medical Center in Houston, Texas, three Critical Care physician/scholars from the Frontline COVID-19 Critical Care Alliance (FLCCC), developers of the MATH+ Hospital Treatment Protocol for COVID-19, presented comprehensive scientific evidence—including Randomized Controlled Trials (RCTs) and Observational Controlled Trials—demonstrating that ivermectin, a key component of [...]